吉林 完善创新链 精准滴灌培育新产品

Core Insights - The "Spring Rain Action" initiated by the National Medical Products Administration in April 2025 aims to promote clinical innovation in Jilin Province, focusing on transforming clinical ideas into viable products [2][5] - As of January 2026, Jilin Province has identified 29 high-quality clinical transformation projects, with 12 third-class medical device projects submitted to the National Medical Products Administration for review [1][5] Group 1: Policy and Implementation - Jilin Province's Medical Products Administration has developed a comprehensive process for project collection, expert review, and follow-up support, emphasizing clinical value-driven innovation [2][4] - Training teams have been organized to educate clinical workers on policy interpretation and project submission processes, ensuring broad participation and high-quality project sources [2][3] Group 2: Project Evaluation and Selection - A multi-dimensional evaluation mechanism has been established to select the most promising projects from the 47 submitted, with 80% focusing on urgent clinical needs [4][5] - On September 30, 2025, 29 projects were selected for review, with a focus on medical devices and diagnostic reagents that align with the province's healthcare goals [4][5] Group 3: Project Support and Development - The Jilin Province Medical Products Administration has implemented a full-chain tracking and nurturing mechanism to support the transformation of selected projects [6][7] - As of the end of 2025, three of the twelve third-class medical device projects have entered clinical trial stages, and five have completed product design, with others progressing as planned [7]